InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57
United States Fiscal year ends December CIK 0000882095
$151.17 +2.77% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $151.17 +122.05% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue30.39Operating income17.63Net income13.50EPS, diluted9.94Fiscal year 2017Revenue26.11 −14.1%Operating income14.12Net income4.63 −65.7%EPS, diluted3.51 −64.7%Fiscal year 2018Revenue22.13 −15.2%Operating income8.20Net income5.46 +17.9%EPS, diluted4.17 +18.8%Fiscal year 2019Revenue22.45 +1.5%Operating income4.29Net income5.39 −1.3%EPS, diluted4.22 +1.2%Fiscal year 2020Revenue24.69 +10.0%Operating income4.07Net income0.12 −97.7%EPS, diluted0.10 −97.6%Fiscal year 2021Revenue27.31 +10.6%Operating income9.92Net income6.23 +4,961.0%EPS, diluted4.93 +4,830.0%Fiscal year 2022Revenue27.28 −0.1%Operating income7.33Net income4.59 −26.2%EPS, diluted3.64 −26.2%Fiscal year 2023Revenue27.12 −0.6%Operating income7.61Net income5.67 +23.4%EPS, diluted4.50 +23.6%Fiscal year 2024Revenue28.75 +6.0%Operating income1.66Net income0.48 −91.5%EPS, diluted0.38 −91.6%Fiscal year 2025Revenue29.44 +2.4%Operating income10.02Net income8.51 +1,672.9%EPS, diluted6.78 +1,684.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 30.39 26.11 22.13 22.45 24.69 27.31 27.28 27.12 28.75 29.44
Growth −14.1% −15.2% +1.5% +10.0% +10.6% −0.1% −0.6% +6.0% +2.4%
Operating income 17.63 14.12 8.20 4.29 4.07 9.92 7.33 7.61 1.66 10.02
Net income 13.50 4.63 5.46 5.39 0.12 6.23 4.59 5.67 0.48 8.51
Growth −65.7% +17.9% −1.3% −97.7% +4,961.0% −26.2% +23.4% −91.5% +1,672.9%
EPS, diluted 9.94 3.51 4.17 4.22 0.10 4.93 3.64 4.50 0.38 6.78
Growth −64.7% +18.8% +1.2% −97.6% +4,830.0% −26.2% +23.6% −91.6% +1,684.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin58.0%Net margin44.4%Free cash flow margin53.6%Fiscal year 2017Operating margin54.1%Net margin17.7%Free cash flow margin43.3%Fiscal year 2018Operating margin37.1%Net margin24.7%Free cash flow margin33.8%Fiscal year 2019Operating margin19.1%Net margin24.0%Free cash flow margin37.1%Fiscal year 2020Operating margin16.5%Net margin0.5%Free cash flow margin30.5%Fiscal year 2021Operating margin36.3%Net margin22.8%Free cash flow margin39.6%Fiscal year 2022Operating margin26.9%Net margin16.8%Free cash flow margin30.6%Fiscal year 2023Operating margin28.0%Net margin20.9%Free cash flow margin27.4%Fiscal year 2024Operating margin5.8%Net margin1.7%Free cash flow margin35.8%Fiscal year 2025Operating margin34.0%Net margin28.9%Free cash flow margin32.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 58.0% 54.1% 37.1% 19.1% 16.5% 36.3% 26.9% 28.0% 5.8% 34.0%
Net margin 44.4% 17.7% 24.7% 24.0% 0.5% 22.8% 16.8% 20.9% 1.7% 28.9%
Free cash flow margin 53.6% 43.3% 33.8% 37.1% 30.5% 39.6% 30.6% 27.4% 35.8% 32.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow17.05Capital expenditure−0.75Free cash flow16.30Buybacks−11.00Dividends paid−2.46Fiscal year 2017Operating cash flow11.90Capital expenditure−0.59Free cash flow11.31 −30.6%Buybacks−0.95Dividends paid−2.73Fiscal year 2018Operating cash flow8.40Capital expenditure−0.92Free cash flow7.48 −33.9%Buybacks−2.90Dividends paid−2.97Fiscal year 2019Operating cash flow9.14Capital expenditure−0.83Free cash flow8.32 +11.3%Buybacks−1.75Dividends paid−3.22Fiscal year 2020Operating cash flow8.17Capital expenditure−0.65Free cash flow7.52 −9.6%Buybacks−1.58Dividends paid−3.45Fiscal year 2021Operating cash flow11.38Capital expenditure−0.58Free cash flow10.81 +43.7%Buybacks−0.55Dividends paid−3.61Fiscal year 2022Operating cash flow9.07Capital expenditure−0.73Free cash flow8.34 −22.8%Buybacks−1.40Dividends paid−3.71Fiscal year 2023Operating cash flow8.01Capital expenditure−0.59Free cash flow7.42 −11.1%Buybacks−1.00Dividends paid−3.81Fiscal year 2024Operating cash flow10.83Capital expenditure−0.52Free cash flow10.31 +38.9%Buybacks−1.15Dividends paid−3.92Fiscal year 2025Operating cash flow10.02Capital expenditure−0.56Free cash flow9.46 −8.2%Buybacks−1.92Dividends paid−4.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 17.05 11.90 8.40 9.14 8.17 11.38 9.07 8.01 10.83 10.02
Capital expenditure −0.75 −0.59 −0.92 −0.83 −0.65 −0.58 −0.73 −0.59 −0.52 −0.56
Free cash flow 16.30 11.31 7.48 8.32 7.52 10.81 8.34 7.42 10.31 9.46
Growth −30.6% −33.9% +11.3% −9.6% +43.7% −22.8% −11.1% +38.9% −8.2%
Buybacks −11.00 −0.95 −2.90 −1.75 −1.58 −0.55 −1.40 −1.00 −1.15 −1.92
Dividends paid −2.46 −2.73 −2.97 −3.22 −3.45 −3.61 −3.71 −3.81 −3.92 −4.00

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash8.23Total debt26.35Net cash (debt)−18.12Shareholders’ equity18.89Debt to equity1.39Fiscal year 2017Cash7.59Total debt33.54Net cash (debt)−25.95Shareholders’ equity20.44Debt to equity1.64Fiscal year 2018Cash17.94Total debt27.32Net cash (debt)−9.38Shareholders’ equity21.39Debt to equity1.28Fiscal year 2019Cash11.63Total debt24.59Net cash (debt)−12.96Shareholders’ equity22.53Debt to equity1.09Fiscal year 2020Cash6.00Total debt31.40Net cash (debt)−25.41Shareholders’ equity18.20Debt to equity1.73Fiscal year 2021Cash5.34Total debt26.70Net cash (debt)−21.36Shareholders’ equity21.07Debt to equity1.27Fiscal year 2022Cash5.41Total debt25.23Net cash (debt)−19.82Shareholders’ equity21.24Debt to equity1.19Fiscal year 2023Cash6.09Total debt24.99Net cash (debt)−18.90Shareholders’ equity22.83Debt to equity1.09Fiscal year 2024Cash9.99Total debt26.71Net cash (debt)−16.72Shareholders’ equity19.33Debt to equity1.38Fiscal year 2025Cash7.56Total debt24.94Net cash (debt)−17.37Shareholders’ equity22.70Debt to equity1.10
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 8.23 7.59 17.94 11.63 6.00 5.34 5.41 6.09 9.99 7.56
Total debt 26.35 33.54 27.32 24.59 31.40 26.70 25.23 24.99 26.71 24.94
Net cash (debt) −18.12 −25.95 −9.38 −12.96 −25.41 −21.36 −19.82 −18.90 −16.72 −17.37
Shareholders’ equity 18.89 20.44 21.39 22.53 18.20 21.07 21.24 22.83 19.33 22.70
Debt to equity 1.39 1.64 1.28 1.09 1.73 1.27 1.19 1.09 1.38 1.10

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
17.05 11.90 8.40 9.14 8.17 11.38 9.07 8.01 10.83 10.02
Growth −30.2% −29.4% +8.9% −10.7% +39.4% −20.3% −11.8% +35.2% −7.5%
Investment
−0.75 −0.59 −0.92 −0.83 −0.65 −0.58 −0.73 −0.59 −0.52 −0.56
calc 16.30 11.31 7.48 8.32 7.52 10.81 8.34 7.42 10.31 9.46
Growth −30.6% −33.9% +11.3% −9.6% +43.7% −22.8% −11.1% +38.9% −8.2%
calc 12.00 8.57 5.72 6.51 5.95 8.56 6.61 5.90 8.21 7.53
−11.99 −16.07 14.36 −7.82 −14.62 −3.13 −2.47 −2.27 −3.45 −4.79
Financing
−9.73 3.39 −12.32 −7.63 0.77 −8.88 −6.47 −5.13 −3.43 −7.75
−2.46 −2.73 −2.97 −3.22 −3.45 −3.61 −3.71 −3.81 −3.92 −4.00
−11.00 −0.95 −2.90 −1.75 −1.58 −0.55 −1.40 −1.00 −1.15 −1.92

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.